Logo image of TR1.DE

T ROWE PRICE GROUP INC (TR1.DE) Stock Fundamental Analysis

FRA:TR1 - Deutsche Boerse Ag - US74144T1088 - Common Stock - Currency: EUR

80.53  +3.3 (+4.27%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to TR1. TR1 was compared to 106 industry peers in the Capital Markets industry. While TR1 has a great health rating, its profitability is only average at the moment. TR1 scores decently on growth, while it is valued quite cheap. This could make an interesting combination. Finally TR1 also has an excellent dividend rating. This makes TR1 very considerable for value and dividend investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year TR1 was profitable.
TR1 had a positive operating cash flow in the past year.
Each year in the past 5 years TR1 has been profitable.
TR1 had a positive operating cash flow in each of the past 5 years.
TR1.DE Yearly Net Income VS EBIT VS OCF VS FCFTR1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

With an excellent Return On Assets value of 15.17%, TR1 belongs to the best of the industry, outperforming 95.28% of the companies in the same industry.
Looking at the Return On Equity, with a value of 19.76%, TR1 belongs to the top of the industry, outperforming 85.85% of the companies in the same industry.
TR1's Return On Invested Capital of 14.11% is amongst the best of the industry. TR1 outperforms 94.34% of its industry peers.
The Average Return On Invested Capital over the past 3 years for TR1 is significantly above the industry average of 8.17%.
Industry RankSector Rank
ROA 15.17%
ROE 19.76%
ROIC 14.11%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
TR1.DE Yearly ROA, ROE, ROICTR1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

TR1 has a Profit Margin of 28.82%. This is in the better half of the industry: TR1 outperforms 77.36% of its industry peers.
TR1's Profit Margin has declined in the last couple of years.
The Operating Margin of TR1 (33.52%) is better than 73.58% of its industry peers.
In the last couple of years the Operating Margin of TR1 has declined.
Industry RankSector Rank
OM 33.52%
PM (TTM) 28.82%
GM N/A
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
TR1.DE Yearly Profit, Operating, Gross MarginsTR1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

Compared to 1 year ago, TR1 has less shares outstanding
The number of shares outstanding for TR1 has been reduced compared to 5 years ago.
TR1 has a better debt/assets ratio than last year.
TR1.DE Yearly Shares OutstandingTR1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
TR1.DE Yearly Total Debt VS Total AssetsTR1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 6.28 indicates that TR1 is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 6.28, TR1 belongs to the best of the industry, outperforming 93.40% of the companies in the same industry.
TR1 has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
TR1 has a Debt to FCF ratio of 0.05. This is amongst the best in the industry. TR1 outperforms 98.11% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that TR1 is not too dependend on debt financing.
TR1 has a better Debt to Equity ratio (0.01) than 88.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Altman-Z 6.28
ROIC/WACCN/A
WACCN/A
TR1.DE Yearly LT Debt VS Equity VS FCFTR1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 3.76 indicates that TR1 has no problem at all paying its short term obligations.
TR1 has a better Current ratio (3.76) than 84.91% of its industry peers.
A Quick Ratio of 3.76 indicates that TR1 has no problem at all paying its short term obligations.
The Quick ratio of TR1 (3.76) is better than 84.91% of its industry peers.
Industry RankSector Rank
Current Ratio 3.76
Quick Ratio 3.76
TR1.DE Yearly Current Assets VS Current LiabilitesTR1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.74% over the past year.
The Earnings Per Share has been growing slightly by 2.42% on average over the past years.
TR1 shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.80%.
Measured over the past years, TR1 shows a small growth in Revenue. The Revenue has been growing by 4.78% on average per year.
EPS 1Y (TTM)10.74%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%-6.3%
Revenue 1Y (TTM)9.8%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%0.78%

3.2 Future

The Earnings Per Share is expected to grow by 3.59% on average over the next years.
Based on estimates for the next years, TR1 will show a small growth in Revenue. The Revenue will grow by 2.79% on average per year.
EPS Next Y-6.08%
EPS Next 2Y-1.5%
EPS Next 3Y-0.96%
EPS Next 5Y3.59%
Revenue Next Year-0.96%
Revenue Next 2Y0.74%
Revenue Next 3Y1.35%
Revenue Next 5Y2.79%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TR1.DE Yearly Revenue VS EstimatesTR1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
TR1.DE Yearly EPS VS EstimatesTR1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

TR1 is valuated reasonably with a Price/Earnings ratio of 9.95.
82.08% of the companies in the same industry are more expensive than TR1, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 28.18. TR1 is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 10.09, the valuation of TR1 can be described as very reasonable.
84.91% of the companies in the same industry are more expensive than TR1, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of TR1 to the average of the S&P500 Index (20.81), we can say TR1 is valued rather cheaply.
Industry RankSector Rank
PE 9.95
Fwd PE 10.09
TR1.DE Price Earnings VS Forward Price EarningsTR1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

TR1's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. TR1 is cheaper than 83.96% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, TR1 is valued cheaper than 82.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.08
EV/EBITDA 6.71
TR1.DE Per share dataTR1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The decent profitability rating of TR1 may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.12
EPS Next 2Y-1.5%
EPS Next 3Y-0.96%

7

5. Dividend

5.1 Amount

TR1 has a Yearly Dividend Yield of 5.76%, which is a nice return.
The stock price of TR1 dropped by -28.57% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 6.56, TR1 pays a better dividend. On top of this TR1 pays more dividend than 84.91% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, TR1 pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.76%

5.2 History

The dividend of TR1 is nicely growing with an annual growth rate of 10.37%!
Dividend Growth(5Y)10.37%
Div Incr Years2
Div Non Decr Years2
TR1.DE Yearly Dividends per shareTR1.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

TR1 pays out 55.55% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of TR1 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP55.55%
EPS Next 2Y-1.5%
EPS Next 3Y-0.96%
TR1.DE Yearly Income VS Free CF VS DividendTR1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
TR1.DE Dividend Payout.TR1.DE Dividend Payout, showing the Payout Ratio.TR1.DE Dividend Payout.PayoutRetained Earnings

T ROWE PRICE GROUP INC

FRA:TR1 (5/2/2025, 7:00:00 PM)

80.53

+3.3 (+4.27%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-24 2025-07-24/amc
Inst Owners79.04%
Inst Owner ChangeN/A
Ins Owners1.67%
Ins Owner ChangeN/A
Market Cap17.90B
Analysts50
Price Target81.19 (0.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.76%
Yearly Dividend4.48
Dividend Growth(5Y)10.37%
DP55.55%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.33%
Min EPS beat(2)-5.31%
Max EPS beat(2)7.98%
EPS beat(4)2
Avg EPS beat(4)3.64%
Min EPS beat(4)-5.31%
Max EPS beat(4)14.18%
EPS beat(8)6
Avg EPS beat(8)6.9%
EPS beat(12)8
Avg EPS beat(12)2.57%
EPS beat(16)10
Avg EPS beat(16)1.76%
Revenue beat(2)0
Avg Revenue beat(2)-4.57%
Min Revenue beat(2)-4.82%
Max Revenue beat(2)-4.33%
Revenue beat(4)1
Avg Revenue beat(4)-3.55%
Min Revenue beat(4)-5.13%
Max Revenue beat(4)0.07%
Revenue beat(8)2
Avg Revenue beat(8)-2.14%
Revenue beat(12)3
Avg Revenue beat(12)-3.03%
Revenue beat(16)3
Avg Revenue beat(16)-2.52%
PT rev (1m)-19.45%
PT rev (3m)-24.52%
EPS NQ rev (1m)-4.88%
EPS NQ rev (3m)-7.72%
EPS NY rev (1m)-6.73%
EPS NY rev (3m)-8.3%
Revenue NQ rev (1m)-1.78%
Revenue NQ rev (3m)-3.04%
Revenue NY rev (1m)-4.94%
Revenue NY rev (3m)-6.33%
Valuation
Industry RankSector Rank
PE 9.95
Fwd PE 10.09
P/S 2.86
P/FCF 16.08
P/OCF 12.04
P/B 1.96
P/tB 2.77
EV/EBITDA 6.71
EPS(TTM)8.09
EY10.05%
EPS(NY)7.98
Fwd EY9.91%
FCF(TTM)5.01
FCFY6.22%
OCF(TTM)6.69
OCFY8.3%
SpS28.14
BVpS41.04
TBVpS29.1
PEG (NY)N/A
PEG (5Y)4.12
Profitability
Industry RankSector Rank
ROA 15.17%
ROE 19.76%
ROCE 18.97%
ROIC 14.11%
ROICexc 17.88%
ROICexgc 28.45%
OM 33.52%
PM (TTM) 28.82%
GM N/A
FCFM 17.79%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
ROICexc(3y)18.71%
ROICexc(5y)21.89%
ROICexgc(3y)30.22%
ROICexgc(5y)33.06%
ROCE(3y)20.58%
ROCE(5y)24.24%
ROICexcg growth 3Y-16.2%
ROICexcg growth 5Y-1.08%
ROICexc growth 3Y-13.37%
ROICexc growth 5Y-6.73%
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Debt/EBITDA 0.02
Cap/Depr 166.63%
Cap/Sales 5.97%
Interest Coverage 250
Cash Conversion 64.04%
Profit Quality 61.74%
Current Ratio 3.76
Quick Ratio 3.76
Altman-Z 6.28
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)130.91%
Cap/Depr(5y)124.54%
Cap/Sales(3y)4.8%
Cap/Sales(5y)4.19%
Profit Quality(3y)84.47%
Profit Quality(5y)86.86%
High Growth Momentum
Growth
EPS 1Y (TTM)10.74%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%-6.3%
EPS Next Y-6.08%
EPS Next 2Y-1.5%
EPS Next 3Y-0.96%
EPS Next 5Y3.59%
Revenue 1Y (TTM)9.8%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%0.78%
Revenue Next Year-0.96%
Revenue Next 2Y0.74%
Revenue Next 3Y1.35%
Revenue Next 5Y2.79%
EBIT growth 1Y16.51%
EBIT growth 3Y-13.78%
EBIT growth 5Y-0.07%
EBIT Next Year3.67%
EBIT Next 3Y4.03%
EBIT Next 5Y4.53%
FCF growth 1Y38.52%
FCF growth 3Y-26.76%
FCF growth 5Y-0.86%
OCF growth 1Y38.27%
OCF growth 3Y-21.25%
OCF growth 5Y2.05%